The increased expression of SRSF3 overexpression in cancer cells causes the improvement of cell cycle performance by influencing the expression levels of G2/M transition regulators, including Forkhead box transcription factor M1 (FoxM1), PLK1, and Cdc25B. This evidence concerns the gene SRSF3 and cancer.